missha signature complexion coordinating bb white broad spectrum spf43 titanium dioxide octinoxate octisalate zinc cream
able c&c co., ltd. - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - titanium dioxide 4.05 mg in 50 ml
missha signature complexion coordinating bb honey beige titanium dioxide octinoxate zinc cream
able c&c co., ltd. - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - titanium dioxide 1.55 mg in 20 ml
missha signature complexion coordinating bb beige broad spectrum spf43 titanium dioxide octinoxate zinc cream
able c&c co., ltd. - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - titanium dioxide 4.96 mg in 50 ml
firdapse- amifampridine phosphate tablet
catalyst pharmaceuticals, inc. - amifampridine phosphate (unii: 8hf8fin815) (amifampridine - unii:ru4s6e2g0j) - firdapse® is indicated for the treatment of lambert-eaton myasthenic syndrome (lems) in adults and pediatric patients 6 years of age and older. firdapse is contraindicated in patients with: - a history of seizures [see warnings and precautions (5.1)] - hypersensitivity to amifampridine phosphate or another aminopyridine [see warnings and precautions (5.2)] pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to firdapse during pregnancy. physicians are encouraged to enroll pregnant patients, or pregnant women may register themselves in the registry by calling 855-212-5856 (toll-free), using the fax number 877-867-1874 (toll-free), by contacting the pregnancy coordinating center at firdapsepregnancyregistry@ubc.com, or by visiting the study website www.firdapsepregnancystudy.com. risk summary there are no data on the developmental risk associated with the use of firdapse in pregnant women. in animal studies, administration of amifampridine phosph
efavirenz/emtricitabine/tenofovir disoproxil zentiva
zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir
leponex 100 mg tablets
devries & co. ltd - clozapine - tablets - clozapine 100 mg - for treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for diath.
leponex 25 mg tablets
devries & co. ltd - clozapine - tablets - clozapine 25 mg - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death.
epitech levetiracetam concentrate for infusion 500mg5ml
averroes pharmaceuticals sdn. bhd. - levetiracetam -
panadol cold+flu-d caplet
glaxosmithkline consumer healthcare sdn. bhd. - paracetamol; phenylephrine hcl; chlorpheniramine maleate -
teva-deferasirox tablet for suspension
teva canada limited - deferasirox - tablet for suspension - 125mg - deferasirox 125mg - heavy metal antagonists